Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

Blood (2020) 135 (15): 1244–1254.

https://doi.org/10.1182/blood.2019003179

Published: 2020

Includes: Supplemental data

Journal Articles

The VLA-4 Integrin Is Constitutively Activated in a Fraction of CD49d-Expressing Chronic Lymphocytic Leukemia Via Autonomous BCR-Mediated Signaling

Blood (2019) 134 (Supplement_1): 849.

https://doi.org/10.1182/blood-2019-124313

Published: 2019

Journal Articles

The VLA-4 Integrin Is Constitutively Activated in a Subset of CD49d-Expressing CLL: A Relationship with the Autonomous BCR-Mediated Signaling?

Blood (2018) 132 (Supplement 1): 5531.

https://doi.org/10.1182/blood-2018-99-111450

Published: 2018

Journal Articles

KRAS , NRAS and BRAF Mutations Are Highly Enriched in TRI12 Chronic Lymphocytic Leukemia and Are Associated to Shorter Time to First Treatment

Elena Vendramini, PhD, Riccardo Bomben, PhD, Federico Pozzo, PhD, Dania Benedetti, PhD, Maria Francesca Rossi, PhD, Michele Dal Bo, PhD, Gabriele Pozzato, MD, Francesco Zaja, MD, Annalisa Chiarenza, MD PhD, Francesco Di Raimondo, MD, Giovanni Del Poeta, MD, Valter Gattei, MD, Antonella Zucchetto

Blood (2018) 132 (Supplement 1): 3113.

https://doi.org/10.1182/blood-2018-99-111864

Published: 2018

Journal Articles

The B-Cell Receptor Signaling Inhibitor Molecules CD305 and CD307b Are Markers of Favorable Prognosis in Chronic Lymphocytic Leukemia with Both Mutated and Unmutated IGHV Gene Status

Dania Benedetti, Claudia Perini, Erika Tissino, Michele Dal Bo, Pietro Bulian, Riccardo Bomben, Francesca Rossi, Massimo Degan, Alessandro Poggi, Mahdi Shabani, Fazel Shokri, Francesco Zaja, MD, Gabriele Pozzato, Annalisa Chiarenza, Francesco Di Raimondo, MD, Giovanni Del Poeta, MD, Valter Gattei, Antonella Zucchetto

Blood (2016) 128 (22): 4358.

https://doi.org/10.1182/blood.V128.22.4358.4358

Published: 2016

Journal Articles

Retention of inside-out VLA-4 Integrin Activation upon B-Cell Receptor Triggering in in-Vitro and in-Vivo Ibrutinib Treated Chronic Lymphocytic Leukemia Cells: Clinical Implication

Erika Tissino, Chiara Caldana, Dania Benedetti, Francesca Rossi, Michele Dal Bo, Pietro Bulian, Riccardo Bomben, Francesco Zaja, MD, Annalisa Chiarenza, Tanja Nicole Hartmann, Alexandre Chigaev, Giovanni Del Poeta, Valter Gattei, Antonella Zucchetto

Blood (2015) 126 (23): 1708.

https://doi.org/10.1182/blood.V126.23.1708.1708

Published: 2015

Journal Articles

The Concomitant High Expression of the B-Cell Receptor Signaling Inhibitor Molecules CD150, CD305, and CD307b Predicts Longer Overall Survival in the Context of Low-Risk Chronic Lymphocytic Leukemia

Antonella Zucchetto, Dania Benedetti, Chiara Caldana, Erika Tissino, Michele Dal Bo, Pietro Bulian, Riccardo Bomben, Francesca Rossi, Francesco Zaja, MD, Gabriele Pozzato, Annalisa Chiarenza, Francesco Di Raimondo, MDPhD, Giovanni Del Poeta, Valter Gattei

Blood (2015) 126 (23): 1720.

https://doi.org/10.1182/blood.V126.23.1720.1720

Published: 2015

Journal Articles

NOTCH1 Mutated IGHV Unmutated Chronic Lymphocytic Leukemia Cells Are Characterized By a Constitutive Overexpression of Nucleophosmin-1 and Ribosome-Associated Components

Blood (2014) 124 (21): 3308.

https://doi.org/10.1182/blood.V124.21.3308.3308

Published: 2014

Journal Articles

NOTCH1 Mutations Are Associated with Low CD20 Expression in Chronic Lymphocytic Leukemia: Evidences for a NOTCH1 -Mediated Epigenetic Regulatory Mechanism

Blood (2014) 124 (21): 296.

https://doi.org/10.1182/blood.V124.21.296.296

Published: 2014

Journal Articles

NOTCH1 Mutations Are Associated with High CD49d Expression in Chronic Lymphocytic Leukemia

Antonella Zucchetto, Chiara Caldana, Federico Pozzo, Silvia Rasi, Carmela Ciardullo, Dania Benedetti, Erika Tissino, Francesca Maria Rossi, Riccardo Bomben, Francesco Zaja, MD, Gabriele Pozzato, Francesco Di Raimondo, MD, Giovanni Del Poeta, Michele Dal Bo, Davide Rossi, MD PhD, Gianluca Gaidano, MD PhD, Valter Gattei

Blood (2014) 124 (21): 1978.

https://doi.org/10.1182/blood.V124.21.1978.1978

Published: 2014

Journal Articles

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

Antonella Zucchetto, Chiara Caldana, Dania Benedetti, Erika Tissino, Francesca Maria Rossi, Evelyn Hutterer, Federico Pozzo, Riccardo Bomben, Michele Dal Bo, Giovanni D’Arena, Francesco Zaja, Gabriele Pozzato, Francesco Di Raimondo, Tanja N. Hartmann, Davide Rossi, Gianluca Gaidano, Giovanni Del Poeta, Valter Gattei

Blood (2013) 122 (19): 3317–3321.

https://doi.org/10.1182/blood-2013-06-507335

Published: 2013

Includes: Supplemental data

Journal Articles

The Elastin Microfibril Interfacer-1 (EMILIN-1) Is a Ligand for CD49d in Chronic Lymphocytic Leukemia Cells

Erika Tissino, Dania Benedetti, Riccardo Bomben, Michele Dal Bo, Tiziana Vaisitti, PhD, Silvia Deaglio, MD, PhD, Davide Rossi, MD, Francesco Zaja, MD, Gabriele Pozzato, MD, Francesco Di Raimondo, Gianluca Gaidano, Giovanni Del Poeta, Alberto Zamò, Paola Spessotto, Roberto Doliana, Antonella Zucchetto, Alfonso Colombatti, Valter Gattei, MD

Blood (2012) 120 (21): 1772.

https://doi.org/10.1182/blood.V120.21.1772.1772

Published: 2012

Journal Articles

CD49d Is Overexpressed in Trisomy 12 Chronic Lymphocytic Leukemia by an Epigenetic-Dependent Transcriptional Control

Antonella Zucchetto, Chiara Caldana, Riccardo Bomben, Erika Tissino, Francesca Maria Rossi, Dania Benedetti, Michele Dal Bo, Davide Rossi, MD, Francesco Zaja, MD, Gabriele Pozzato, MD, Francesco Di Raimondo, Gianluca Gaidano, MD, PhD, Giovanni Del Poeta, Valter Gattei, MD

Blood (2012) 120 (21): 929.

https://doi.org/10.1182/blood.V120.21.929.929

Published: 2012

Journal Articles

Circulating CLL Cells Expressing CD49d Display a Phospho-Proteomic Profile Consistent with a Constitutive Receptor Engagement by Blood-Borne Ligands

Dania Benedetti, Erika Tissino, Daniela Marconi, Michele Dal Bo, Riccardo Bomben, Tiziana Vaisitti, PhD, Silvia Deaglio, MD, PhD, Davide Rossi, MD, Gianluca Gaidano, MD, PhD, Gabriele Pozzato, MD, Francesco Di Raimondo, Giovanni Del Poeta, Amy VanMeter, Antonella Zucchetto, Virginia Espina, Lance Liotta, Valter Gattei, MD

Blood (2012) 120 (21): 930.

https://doi.org/10.1182/blood.V120.21.930.930

Published: 2012

Journal Articles

Nucleophosmin-1 and Ribosome-Associated Components Are Constitutively Overexpressed in NOTCH1 Mutated IGHV Unmutated CLL

Michele Dal Bo, Federico Pozzo, Riccardo Bomben, Antonella Zucchetto, Erika Tissino, Dania Benedetti, Massimo Degan, Francesca Maria Rossi, Pietro Bulian, MD, Tiziana D'Agaro, Sara Dereani, Davide Rossi, MD, Alberto Zamò, Francesco Zaja, Gabriele Pozzato, MD, Francesco Di Raimondo, Gianluca Gaidano, MD, PhD, Giovanni Del Poeta, Valter Gattei, MD

Blood (2012) 120 (21): 3880.

https://doi.org/10.1182/blood.V120.21.3880.3880

Published: 2012

Journal Articles

The Mir-17~92 Cluster Family Determines the Responsiveness of CLL Cells with Unmutated IGHV Genes to Toll-Like Receptor 9 Triggering

Riccardo Bomben, Stefano Volinia, Stefania Gobessi, Daniela Marconi, Michele Dal Bo, Dania Benedetti, Giovanni Del Poeta, Luca Laurenti, Dimitar G Efremov, Valter Gattei

Blood (2010) 116 (21): 2407.

https://doi.org/10.1182/blood.V116.21.2407.2407

Published: 2010

Journal Articles

Chronic Lymphocytic Leukemia Subset Expressing Mutated IGHV3-23 Has Peculiar Clinical and Biological Features.

Blood (2009) 114 (22): 1256.

https://doi.org/10.1182/blood.V114.22.1256.1256

Published: 2009

Journal Articles

ZAP-70 Expression Evaluated by Mean Fluorescence Intensity T/B Ratio Is a More Useful Prognosticator Than Percentage of Positive Cells in Chronic Lymphocytic Leukemia (CLL).

Francesca Maria Rossi, Maria Ilaria Del Principe, Davide Rossi, Maria Irno Consalvo, Fabrizio Luciano, Antonella Zucchetto, Pietro Bulian, Riccardo Bomben, Dania Benedetti, Michele Dal-Bo, Massimo Degan, Gianluca Gaidano, Giovanni Del Poeta, Valter Gattei

Blood (2009) 114 (22): 1257.

https://doi.org/10.1182/blood.V114.22.1257.1257

Published: 2009

Journal Articles

CD49d Expression Identifies a Chronic Lymphocytic Leukemia (CLL) Subset with High Levels of Circulating CD34 + Cells Co-Expressing Endothelial Cell Markers.

Francesca Maria Rossi, Davide Rossi, Antonella Zucchetto, Riccardo Bomben, Michele Dal Bo, Dania Benedetti, Claudio Tripodo, Gabriele Pozzato, Gianluca Gaidano, Giovanni Del Poeta, Valter Gattei

Blood (2009) 114 (22): 2329.

https://doi.org/10.1182/blood.V114.22.2329.2329

Published: 2009

Journal Articles

CD38 CD49d Are Physically and Functionally Associated in B-Cell Chronic Lymphocytic Leukemia Cells.

Antonella Zucchetto, Tiziana Vaisitti, Dania Benedetti, Riccardo Bomben, Michele Dal-Bo, Massimo Degan, Giovanni Del Poeta, Valter Gattei, Fabio Malavasi, MD, PhD, Silvia Deaglio, MD, PhD

Blood (2009) 114 (22): 357.

https://doi.org/10.1182/blood.V114.22.357.357

Published: 2009

NARROW

CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

The VLA-4 Integrin Is Constitutively Activated in a Fraction of CD49d-Expressing Chronic Lymphocytic Leukemia Via Autonomous BCR-Mediated Signaling

The VLA-4 Integrin Is Constitutively Activated in a Subset of CD49d-Expressing CLL: A Relationship with the Autonomous BCR-Mediated Signaling?

KRAS , NRAS and BRAF Mutations Are Highly Enriched in TRI12 Chronic Lymphocytic Leukemia and Are Associated to Shorter Time to First Treatment

The B-Cell Receptor Signaling Inhibitor Molecules CD305 and CD307b Are Markers of Favorable Prognosis in Chronic Lymphocytic Leukemia with Both Mutated and Unmutated IGHV Gene Status

Retention of inside-out VLA-4 Integrin Activation upon B-Cell Receptor Triggering in in-Vitro and in-Vivo Ibrutinib Treated Chronic Lymphocytic Leukemia Cells: Clinical Implication

The Concomitant High Expression of the B-Cell Receptor Signaling Inhibitor Molecules CD150, CD305, and CD307b Predicts Longer Overall Survival in the Context of Low-Risk Chronic Lymphocytic Leukemia

NOTCH1 Mutated IGHV Unmutated Chronic Lymphocytic Leukemia Cells Are Characterized By a Constitutive Overexpression of Nucleophosmin-1 and Ribosome-Associated Components

NOTCH1 Mutations Are Associated with Low CD20 Expression in Chronic Lymphocytic Leukemia: Evidences for a NOTCH1 -Mediated Epigenetic Regulatory Mechanism

NOTCH1 Mutations Are Associated with High CD49d Expression in Chronic Lymphocytic Leukemia

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

The Elastin Microfibril Interfacer-1 (EMILIN-1) Is a Ligand for CD49d in Chronic Lymphocytic Leukemia Cells

CD49d Is Overexpressed in Trisomy 12 Chronic Lymphocytic Leukemia by an Epigenetic-Dependent Transcriptional Control

Circulating CLL Cells Expressing CD49d Display a Phospho-Proteomic Profile Consistent with a Constitutive Receptor Engagement by Blood-Borne Ligands

Nucleophosmin-1 and Ribosome-Associated Components Are Constitutively Overexpressed in NOTCH1 Mutated IGHV Unmutated CLL

The Mir-17~92 Cluster Family Determines the Responsiveness of CLL Cells with Unmutated IGHV Genes to Toll-Like Receptor 9 Triggering

Chronic Lymphocytic Leukemia Subset Expressing Mutated IGHV3-23 Has Peculiar Clinical and Biological Features.

ZAP-70 Expression Evaluated by Mean Fluorescence Intensity T/B Ratio Is a More Useful Prognosticator Than Percentage of Positive Cells in Chronic Lymphocytic Leukemia (CLL).

CD49d Expression Identifies a Chronic Lymphocytic Leukemia (CLL) Subset with High Levels of Circulating CD34 + Cells Co-Expressing Endothelial Cell Markers.

CD38 CD49d Are Physically and Functionally Associated in B-Cell Chronic Lymphocytic Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only